Rhode Island Hospital and The Miriam Hospital name neuropathologist Douglas C. Anthony, M.D., Ph.D., chief of pathology

Posted Tuesday, January 31, 2012

Rhode Island Hospital and The Miriam Hospital have appointed Douglas C. Anthony, M.D., Ph.D., as chief of pathology. In this role, which becomes effective Feb. 1, 2012, Anthony will lead the clinical, educational and research pathology programs for Lifespan. Additionally, Anthony will help bridge pathology and the neurosciences through the Norman Prince Neuroscience Institute, and will help to further develop the personalized medicine model.

“Dr. Anthony’s neurology experience is a significant complement to his pathology training, and makes him an invaluable addition to our clinical staff,” said Timothy J. Babineau, M.D., president and chief executive officer of Rhode Island Hospital and The Miriam Hospital. “This appointment further demonstrates our commitment to becoming a leader in the neurosciences. I am confident that Dr. Anthony will play a pivotal role on our clinical team, and will further enhance our efforts to improve patient care and the patient experience.”

Anthony comes to Rhode Island and The Miriam hospitals from the University of Missouri, where he served as chair of the department of pathology and anatomical sciences and professor of neurology.  At the University of Missouri Health Care he served as chief of pathology and medical director of pathology clinical laboratories. He also served as a pathologist at the Harry S. Truman Veterans Administration Medical Center, Women and Children’s Hospital, and the Ellis Fischel Cancer Center, and as a neuropathologist for the Office of the Medical Examiner in Boone, Callaway and Greene counties in Missouri.  Previously, he was on the faculty at Harvard Medical School and served as a neuropathologist at Boston Children’s Hospital, Brigham and Women’s Hospital, and as a neuropathologist consultant to the Office of the Chief Medical Examiner for the Commonwealth of Massachusetts.

Anthony earned his bachelor’s degree in chemical engineering from Washington University in St. Louis, Mo.; his doctoral degree in experimental pathology from Duke University; and his medical degree from Duke University.  He completed his residency in pathology and a fellowship in neuropathology at Duke University Medical Center.

He is a member of the United States and Canadian Academy of Pathology; the American Association of Neuropathologists; the College of American Pathologists; the Society for Neuroscience; Society of Toxicology; and the American Society for Neurochemistry, among others. He has served on several editorial boards, including the Journal of Neuropathology and Experimental Neurology; Advances in Anatomic Pathology; and Pediatric Pathology and Molecular Medicine, and is an author of the neuroscience sections of Robbins and Cotran Pathologic Basis of Disease. He has won numerous awards, including the Dr. Edison H. and Sallie Y. Miyawaki Teaching Award in Neurosciences at Harvard Medical School; the Excellence in Education Award in pre-clinical sciences at the University of Missouri; and the Order of Socrates award at the School of Medicine at the University of Missouri.

Anthony’s research interests include the biology of axons and its relevance to diseases of peripheral nerves, and the pathobiology of brain tumors.

Filed under: Lifespan,RIH,